BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24381427)

  • 1. A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease.
    Mishra S; Yadav D; Gupta M; Mishra H; Sharma P
    Indian J Clin Biochem; 2013 Jan; 28(1):79-83. PubMed ID: 24381427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinsulinemia predisposes to NAFLD.
    Mishra S; Yadav D; Gupta M; Mishra H; Sharma P
    Indian J Clin Biochem; 2008 Apr; 23(2):130-5. PubMed ID: 23105738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of Correlation between Non Alcoholic Fatty Liver Disease and Carotid Atherosclerosis.
    Sagar A; L R; Farheen SA
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study.
    Lankarani KB; Mahmoodi M; Lotfi M; Zamiri N; Heydari ST; Ghaffarpasand F; Fallahzadeh MK; Babaeinejad M; Maharlouei N; Mirzaee O; Geramizadeh B; Peymani P
    Korean J Gastroenterol; 2013 Dec; 62(6):344-51. PubMed ID: 24365733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
    Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
    Bajaj S; Prajapati SK
    J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease.
    Sert A; Pirgon O; Aypar E; Yılmaz H; Dündar B
    J Clin Res Pediatr Endocrinol; 2013 Sep; 5(3):182-8. PubMed ID: 24072087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
    Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
    J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Morbidity in Polycystic Ovarian Syndrome.
    Nath J; Sharma S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
    Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
    Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Zenari L; Zoppini G; Falezza G
    J Endocrinol Invest; 2006 Jan; 29(1):55-60. PubMed ID: 16553034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Between Carotid Intima Media Thickness and Non-Alcoholic Fatty Liver Disease.
    Kumari S; Porwal YC; Gupta R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.
    Başar O; Akbal E; Köklü S; Tuna Y; Koçak E; Başar N; Tok D; Erbiş H; Senes M
    Herz; 2013 Jun; 38(4):417-22. PubMed ID: 23324907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.
    Kim SK; Choi YJ; Huh BW; Park SW; Lee EJ; Cho YW; Huh KB
    J Clin Endocrinol Metab; 2014 May; 99(5):1879-84. PubMed ID: 24512497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease.
    Kilciler G; Genc H; Tapan S; Ors F; Kara M; Karadurmus N; Ercin CN; Karslioglu Y; Kilic S; Bagci S; Erbil MK; Dogru T
    Ups J Med Sci; 2010 Nov; 115(4):253-9. PubMed ID: 20731535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
    Dogru T; Genc H; Tapan S; Ercin CN; Ors F; Aslan F; Kara M; Sertoglu E; Bagci S; Kurt I; Sonmez A
    Diabetes Res Clin Pract; 2012 Apr; 96(1):47-52. PubMed ID: 22189171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.